An Exploratory Study of Telaprevir in Treatment-Naive Participants With Chronic Genotype 4 Hepatitis C Virus Infection

NCT00580801 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatitis C

Interventions

DRUG: Telaprevir
DRUG: Pegylated-interferon-alfa-2a
DRUG: Placebo
DRUG: Ribavirin

Sponsor

Tibotec BVBA